Social Cognition and Interaction Training for Schizophrenia
Social Cognition and Interaction Training for Schizophrenia
批准号:
7425957
负责人:
DAVID Lewis PENN
金额:
$21.08万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-01 至 2010-05-31
关键词:
AddressAgeAntipsychotic AgentsApplied ResearchAudiotapeCaringClientClipCognitiveCognitive deficitsCognitive remediationCommunitiesConditionCuesDataDelusionsDevelopmentDiagnosticDiagnostic and Statistical ManualDiseaseEffectivenessEmotionsEmpirical ResearchEvaluationFeedbackFemaleFilmGrantIndividualInpatientsInterventionLiteratureManualsMediator of activation proteinMedicalMindNIH Program AnnouncementsNeurocognitionNeurocognitiveNumbersOnset of illnessOutcomeOutpatientsParanoiaParticipantPerceptionPersonal SatisfactionPharmaceutical PreparationsPhaseProcessProtocols documentationQuality of lifeRandomizedRandomized Controlled TrialsRangeRateRecruitment ActivityResearchSchizoaffective DisordersSchizophreniaSeriesServicesSocial FunctioningSpecificityStagingSubstance AddictionSupervisionSymptomsTestingTrainingTraining ProgramsTraining SupportWorkWritingbasecognitive functioncognitive neurosciencefollow-upfunctional disabilityfunctional outcomesimprovedmaleprogramspsychosocialrelating to nervous systemresponsesizeskills trainingsocialsocial cognitionsocial skillstheoriestherapy developmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The proposed project is a phase 3 treatment development study to conduct a preliminary evaluation of the effectiveness of the Social Cognition and Interaction (SCIT) program. SCIT is a group treatment that is provided in 50-minute weekly sessions over six months. Fifty six individuals with schizophrenia or schizoaffective disorder will be randomly assigned to one of two conditions: 1) SCIT (n=28), or 2) Treatment as usual (TAU) (n=28). All individuals will continue to receive usual medical care for their disorder including antipsychotic medication. Participants must meet DSM IV criteria for schizophrenia or schizoaffective disorder, not meet current criteria for substance dependence, and have difficulty interacting with others. In addition, participants must be between the ages of 25-60, male or female, any ethnic background, and have an IQ greater than 70. Participants will be assessed at baseline, post-treatment (6 months), and 6 months after completing treatment on a small number of well-defined outcomes (due to the small size of the pilot RCT), including social cognition, social functioning, quality of life, and symptoms. Fidelity of clinicians to the treatment manual will be assessed by weekly supervision, audiotaping the therapy sessions, and utilization of fidelity scales. Data on paranoia and neurocognition, potential moderating variables, will be collected at baseline. Stakeholder (client and therapist) feedback will be obtained at post-treatment only, so as to inform possible revisions to the treatment manual.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Social Cognition and Interaction Training for Schizophrenia
-
批准号:7241834
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2007
-
负责人:DAVID Lewis PENN
-
依托单位:
Social Cognition and Interaction Training for Schizophrenia
-
批准号:7625952
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2007
-
负责人:DAVID Lewis PENN
-
依托单位:
Graduated Recovery Intervention for Early Schizophrenia
-
批准号:7059851
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2005
-
负责人:DAVID Lewis PENN
-
依托单位:
Graduated Recovery Intervention for Early Schizophrenia
-
批准号:7215212
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2005
-
负责人:DAVID Lewis PENN
-
依托单位:
Graduated Recovery Intervention for Early Schizophrenia
-
批准号:6923389
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2005
-
负责人:DAVID Lewis PENN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: